Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pMEG_BB3_YL68N_AE
(Plasmid #117832)

Ordering

Item Catalog # Description Quantity Price (USD)
Plasmid 117832 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.

Backbone

  • Vector backbone
    pMEG_BB3_YL68N_AE
  • Backbone size (bp) 4193
  • Vector type
    Bacterial Expression, Yeast Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Nourseothricin (clonNat), 50 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    None

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Contains 34 bp GoldenMOCS-Yali Linker AB

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pMEG_BB3_YL68N_AE was a gift from Michael Sauer (Addgene plasmid # 117832 ; http://n2t.net/addgene:117832 ; RRID:Addgene_117832)
  • For your References section:

    Golden Gate based metabolic engineering strategy for wild-type strains of Yarrowia lipolytica. Egermeier M, Sauer M, Marx H. FEMS Microbiol Lett. 2019 Jan 29. pii: 5304171. doi: 10.1093/femsle/fnz022. 10.1093/femsle/fnz022 PubMed 30698703